the aid library

LIST OPTIONS

Filter

4107

HIV Programme Review in Belarus

D. Raben; J. Klinte; A. Sönnerborg; E. Subata, World Health Organization (Europe); Centre for Health & Infectious Disease Research (2015) C_WHO

Evaluation report November 2014

Download (98)

View PDF (153)

HIV/AIDS treatment and care in Georgia

D. Raben; S. F. Jakobsen; J. Klinte; J.Lundgren World Health Organization (Europe); Centre for Health & Infectious Disease Research (2014) C_WHO

Evaluation report September 2014

Download (88)

View PDF (165)

HIV/AIDS Programme in Kyrgyzstan

M. Mansfeld; M. Ristola; G. Likatavicius World Health Organization (Europe); Centre for Health & Infectious Disease Research (2015) C_WHO

Evaluation report December 2014

Download (99)

View PDF (160)

HIV Programme Review in Tajikistan

M. Mansfeld; M. Ristola; J. Klinte; et al. World Health Organization (Europe); Centre for Health & Infectious Disease Research (2015) C_WHO

Evaluation report September 2014

Download (124)

View PDF (152)

Optimization of ART in Ukraine: general principles of ART optimization from a public health perspective

Professor J. Lundgren World Health Organization (Europe); Centre for Health & Infectious Disease Research (2016) C_WHO

Mission report April 2016

Download (91)

View PDF (139)

HIV/AIDS treatment and care in Estonia

D. Raben; S. F. Jakobsen; F. Nakagawa; et al. World Health Organization (Europe); WHO Collaborating Centre on HIV and Viral Hepatitis; Centre for Health & Infectious Disease Research (CHIP) (2014) C_WHO

HIVi/AIDSi ravi ja hooldus Eestis

D. Raben; S. F. Jakobsen; F. Nakagawa; et al. Maailma Terviseorganisatsioon (Euroopa); WHO Collaborating Centre on HIV and Viral Hepatitis; Centre for Health & Infectious Disease Research (CHIP) (2014) C_WHO

Hindamisaruanne Juuni 2014

Download (154)

View PDF (219)

Guideline for Disinfection and Sterilization in Healthcare Facilities

Centers for Disease Control and Prevention (CDC) (2019) C_CDC

The Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008, presents evidence- based recommendations on the preferred methods for cleaning, disinfection and sterilization of patient- care medical devices and for cleaning and disinfecting the healthcare environment. This docume... more

External Link

Management of healthcare workers returning from Ebola-affected areas

European Centre for Disease Prevention and Control (2015) CC2

Infection prevention and control measures for Ebola virus disease

Interim guidance for healthcare providers and Zika virus laboratory diagnosis
recommended

European Centre for Disease Prevention and Control (2016) C1

This document aims to present an algorithm for deciding whom to test and provide guidance on the laboratory tests for Zika virus infection diagnosis in order to support clinical diagnostic and case reporting through surveillance among EU Member States. The algorithm is not intended for clinical man... more

Download (253)

View PDF (467)

A WHO / The Union Monograph on TB and Tobacco Control

International Union Against Tuberculosis and Lung Disease, World Health Organization (2007) C_WHO

Joining efforts to control two trelated global epidemics.

COVID-19 in India: Potential Impact of the Lockdown and Other Longer-Term Policies

Schueller, E.; et al. The Center For Disease Dynamics, Economics & Policy; et al. (2020) CC

19 April 2020 To contain the spread of COVID-19 and to keep infections at a manageable level, many countries have instituted lockdowns and social distancing. In India, a nationwide 21-day lockdown was announced with effect from 25 March 2020. This lockdown is expected to avert a sudden and large in... more

The State of the World’s Antibiotics Report 2021

Siriam, A.; et al. The Center For Disease Dynamics, Economics & Policy CDDEP (2021) CC

A Global Analysis of Antimicrobial Resistance and Its Drivers. Since the first State of the World’s Antibiotics report in 2015, antimicrobial resistance has leveled off in some high-income countries but continues to rise in many low- and middle-income countries (LMICs), where access to antibiotic... more

Towards One Health preparedness: expert consultation 11–12 December 2017

European Centre for Disease Prevention and Control ECDC (2018) CC

Climate change, increasing population densities, and intensified globalisation in trade, travel and migration are among the most important factors shaping the 21st century. Each impacts upon population health and the risk of infectious disease, particularly those originating at the human-animal-envi... more

External Link

Situation Analysis: Antibiotic use and resistance in South Africa

The Center for Disease Dynamics, Economics & Policy CDDEP (2011) C2

South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p... more

Monkeypox multi-country outbreak. Rapid Risk Assessment

European Centre for Disease Prevention and Control (ECDC) (2022) C2

Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands). Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact ... more

Situational Analysis Report on Antimicrobial Resistance in Pakistan

The Center for Disease Dynamics, Economics & Policy CDDEP (2016) C2

Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet... more

Download (187)

View PDF (178)

Operational considerations for the provision of the HIV continuum of care

European Centre for Disease Prevention and Control ECDC (2022) C1

This document provides an overview of key considerations for the provision of the HIV continuum of care in the context of displaced people from Ukraine in the EU/EEA. This document has two aims: firstly, to outline what is known of the Ukrainian HIV epidemic, and secondly, to use the HIV continuum o... more

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Download (1648)

View PDF (3024)

Workplace Pandemic Preparedness. Facilitator Training Manual

Ministry of Health Ghana; NADMO Ghana GiZ Deutsche Gesellschaft für Internationale Zusammenarbeit (2013) C1

Interim guidance for healthcare providers and Zika virus laboratory diagnosis recommended

Interim guidance for healthcare providers and Zika virus laboratory diagnosis
recommended